NEUBLASTIN Uses, Dosage, Side Effects and more
NEUBLASTIN is under investigation in clinical trial NCT01842126 (Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)).
| Attribute | Details |
|---|---|
| Trade Name | NEUBLASTIN |
| Generic | Artemin |
| Artemin Other Names | NEUBLASTIN |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
